X SCRIBE THERAPEUTICS Trademark

Trademark Overview


On Thursday, June 23, 2022, a trademark application was filed for X SCRIBE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the X SCRIBE THERAPEUTICS trademark a serial number of 97473474. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, June 11, 2024. This trademark is owned by Scribe Therapeutics Inc.. The X SCRIBE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; Molecular diagnostic services in the nature of genetic testing for medical research purposes
x scribe therapeutics

General Information


Serial Number97473474
Word MarkX SCRIBE THERAPEUTICS
Filing DateThursday, June 23, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wordings "SCRIBE" above "THERAPEUTICS", all to the right of a stylized letter "X" partially formed by horizontal lines displayed atop a circle outline.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesScientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; Molecular diagnostic services in the nature of genetic testing for medical research purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 12, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameScribe Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlameda, CA 94501

Party NameScribe Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94501

Trademark Events


Event DateEvent Description
Monday, June 27, 2022NEW APPLICATION ENTERED
Tuesday, July 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 13, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Thursday, March 16, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 16, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 16, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 16, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, December 10, 2023SOU TEAS EXTENSION RECEIVED
Sunday, December 10, 2023SOU EXTENSION 1 FILED
Sunday, December 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, December 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2024SOU EXTENSION 2 GRANTED
Tuesday, June 11, 2024SOU EXTENSION 2 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED